The results demonstrated that lentiviral packaged ShRNA‐SPIN1 could inhibit GC tumor growth, which indicated that SPIN1 might be a promising target for GC therapeutics, and LV‐ShRNA‐SPIN1 gene therapy may be a promising novel approach to treat advanced GC. The gene discussed is SPIN1; the disease is gastric cancer.